Fungal Infection
Superficial fungal infection is the most prevalent skin disease. Detection of the pathogen from a lesion by mycological tests is essentially important. Superficial infections are usually successfully treated with topical antimycotics. Onychomycoses and ha
- PDF / 17,345,942 Bytes
- 744 Pages / 325.984 x 469.464 pts Page_size
- 4 Downloads / 186 Views
Thomas Krieg David R. Bickers Yoshiki Miyachi (Eds.)
Therapy of Skin Diseases A Worldwide Perspective on Therapeutic Approaches and Their Molecular Basis
Prof. Yoshiki Miyachi Kyoto University Graduate School of Medicine Dept. Dermatology & Cutaneous Sciences 54 Kawahara-cho Shogoin, Sakyo-ku Kyoto 606-8507 Japan [email protected]
Prof. Thomas Krieg Universitätsklinikum Köln Klinik und Poliklinik für Dermatologie und Venerologie Kerpener Str. 62 50924 Köln Germany [email protected] Prof. David R. Bickers Columbia University Medical Center Dept. Dermatology 12th Floor, Herbert Irving Pavilion 161 Fort Washington Ave. New York NY 10032 USA [email protected]
ISBN: 978-3-540-78813-3
e-ISBN: 978-3-540-78814-0
DOI: 10.1007/978-3-540-78814-0 Springer Heidelberg Dordrecht London New York Library of Congress Control Number: 2009933266 © Springer-Verlag Berlin Heidelberg 2010 This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer. Violations are liable to prosecution under the German Copyright Law. The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Product liability: The publishers cannot guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such information by consulting the relevant literature. Cover design: eStudio Calamar, Figueres/Berlin Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com)
Preface
Treatment of skin diseases has changed remarkably during the last decade. This is largely the result of a better understanding of the molecular and cellular basis of many skin diseases. Thus, novel targets have been identified and specific drugs developed which directly interfere with or alter the disease processes. This change is readily apparent when considering the novel agents available for psoriasis and atopic dermatitis, and also for viral and other infectious skin diseases. Interestingly, many of these new agents are administered systemically either orally or by subcutaneous injection. And yet, as with all forms of drug therapy, these highly efficacious agents can also be associated with severe side effects and drug-induced toxicity. Accordingly, the dermatologist must be aware of the medical status of the patient as well as all other medications that are being prescribed concomitantly. Careful moni
Data Loading...
